Your browser is no longer supported. Please, upgrade your browser.
Settings
OCLS Oculus Innovative Sciences, Inc. daily Stock Chart
OCLS [NASD]
Oculus Innovative Sciences, Inc.
Index- P/E- EPS (ttm)-2.93 Insider Own0.60% Shs Outstand4.23M Perf Week22.01%
Market Cap18.99M Forward P/E- EPS next Y-1.23 Insider Trans33.21% Shs Float4.18M Perf Month-4.67%
Income-10.40M PEG- EPS next Q-0.59 Inst Own9.10% Short Float2.79% Perf Quarter360.51%
Sales15.20M P/S1.25 EPS this Y27.20% Inst Trans-23.77% Short Ratio1.28 Perf Half Y349.00%
Book/sh1.85 P/B2.43 EPS next Y39.70% ROA-81.80% Target Price7.00 Perf Year304.50%
Cash/sh1.18 P/C3.80 EPS next 5Y- ROE-110.10% 52W Range0.78 - 4.98 Perf YTD290.43%
Dividend- P/FCF- EPS past 5Y21.80% ROI-99.50% 52W High-9.84% Beta1.06
Dividend %- Quick Ratio2.40 Sales past 5Y9.10% Gross Margin47.70% 52W Low475.64% ATR0.28
Employees38 Current Ratio3.00 Sales Q/Q2.70% Oper. Margin-68.50% RSI (14)65.22 Volatility7.55% 6.72%
OptionableNo Debt/Eq0.01 EPS Q/Q20.70% Profit Margin-68.30% Rel Volume1.22 Prev Close4.55
ShortableYes LT Debt/Eq0.00 EarningsJul 28 AMC Payout- Avg Volume90.67K Price4.49
Recom2.00 SMA2015.37% SMA5024.50% SMA200166.56% Volume110,719 Change-1.32%
Jun-26-15Initiated Maxim Group Buy $3
Apr-19-13Reiterated Maxim Group Buy $2.80 → $6
Dec-14-10Initiated Rodman & Renshaw Mkt Outperform $3
Aug-18-09Initiated Dawson James Buy $4.50
Nov-07-08Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
Aug-06-08Reiterated Rodman & Renshaw Mkt Outperform $14 → $12
Apr-11-08Reiterated Rodman & Renshaw Mkt Outperform $16 → $14
Jul-18-07Reiterated Rodman & Renshaw Mkt Outperform $13 → $16
Jun-21-07Initiated Rodman & Renshaw Mkt Outperform $13
Mar-27-07Initiated Roth Capital Buy $10
Aug-24-16 05:05AM  Oculus Innovative Sciences Receives U.S. FDA Approval for New Post-Dermal-Procedures Product for Removal of Foreign Material Including Microorganisms GlobeNewswire +14.32%
Aug-18-16 01:04PM  OCULUS INNOVATIVE SCIENCES, INC. Financials
Aug-17-16 09:07AM  SECFilings.com: Oculus Innovative Sciences (OCLS) Tackling Eczema From the Inside Out and Outside In Marketwired
Aug-12-16 11:35AM  Edited Transcript of OCLS earnings conference call or presentation 28-Jul-16 8:30pm GMT
Aug-11-16 04:05AM  Oculus Innovative Sciences Receives Australian Approvals to Market Sterile Microcyn®-Based Antimicrobial Solutions and Hydrogel Dressings GlobeNewswire
Aug-09-16 04:33PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-Q, Quarterly Report
Aug-04-16 09:09AM  SECFilings.com: OCLS Keeping in Step With Innovation and US Dermatology Market Penetration Marketwired
Jul-29-16 04:26PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements -9.54%
01:44PM  ETFs with exposure to Oculus Innovative Sciences, Inc. : July 29, 2016
Jul-28-16 04:06PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme
04:05PM  Oculus Innovative Sciences Reports Financial Results for First Quarter of Fiscal Year 2017 GlobeNewswire
07:07AM  Q1 2017 Oculus Innovative Sciences Inc Earnings Release - After Market Close
Jul-26-16 09:19AM  Oculus Innovative Sciences, Inc. :OCLS-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016
Jul-19-16 12:56PM  ETFs with exposure to Oculus Innovative Sciences, Inc. : July 19, 2016
04:05AM  Oculus Innovative Sciences Announces Fiscal First Quarter 2017 Financial Results and Conference Call GlobeNewswire
Jul-06-16 04:05AM  Oculus Innovative Sciences Announces Record Monthly and Quarterly Prescription Data GlobeNewswire +8.21%
Jun-28-16 04:25PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,
Jun-27-16 09:38AM  SECFilings.com Examines Oculus Innovative Sciences' Financial Results and Turnaround Plan Marketwired +364.16%
07:03AM  Splits Calendar: Oculus Innovative Sciences splits before market open today (1:5 ratio)
Jun-23-16 01:47PM  ETFs with exposure to Oculus Innovative Sciences, Inc. : June 23, 2016
Jun-22-16 12:34PM  Oculus Innovative Sciences, Inc. :OCLS-US: Earnings Analysis: Q4, 2016 By the Numbers : June 22, 2016 -8.78%
05:05AM  Oculus Innovative Sciences Announces Reverse Split of Common Stock GlobeNewswire
Jun-21-16 04:27PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-K, Annual Report
Jun-17-16 11:59AM  Edited Transcript of OCLS earnings conference call or presentation 16-Jun-16 8:30pm GMT
Jun-16-16 04:30PM  Oculus Innovative Sciences Inc Earnings Call scheduled for 4:30 pm ET today
04:09PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme
04:05PM  Oculus Innovative Sciences Reports Financial Results for Fiscal Year 2016 and Fourth Quarter Ending March 31, 2016 GlobeNewswire
07:07AM  Q4 2016 Oculus Innovative Sciences Inc Earnings Release - After Market Close
Jun-02-16 04:05AM  Oculus Innovative Sciences Announces Financial Results for the Fiscal Year/Fourth Quarter 2016 and Conference Call GlobeNewswire
May-17-16 06:11PM  Can virtual reality translate into real profits?
May-03-16 04:05AM  Oculus Innovative Sciences Launches New Ceramax Skin Barrier Cream in the United States GlobeNewswire
Apr-28-16 04:05AM  Oculus Innovative Sciences to Present at Pioneers 2016 Investor Conference Hosted by Joseph Gunnar & Company in New York City GlobeNewswire
Apr-27-16 04:05AM  Oculus Innovative Sciences to Present at the Third Annual Growth Capital Expo MicroCap Investor Conference in Las Vegas GlobeNewswire
Apr-26-16 09:20AM  Data Shows Oculus Delivering on Promise to Grow U.S. Dermatology Sales Accesswire
Apr-20-16 02:35PM  Oculus Innovative Sciences Surges 26%: Here's Why +18.28%
12:57PM  Top Stocks on 4/20: Investors Are Considering These on Wednesday April 20th Accesswire
10:07AM  4 Promising Small Cap Stocks That You Need To Know About Accesswire
04:05AM  Oculus Innovative Sciences Receives U.S. FDA Approval for Lasercyn for Use Following Laser Procedures, Microdermabrasions and Chemical Peels GlobeNewswire
Apr-13-16 04:05AM  Oculus Innovative Sciences Receives European Approval to Market Sinudox Indicated for Use in Nasal Irrigation GlobeNewswire
Apr-06-16 04:05AM  Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Allowance of New Patents for Microcyn® Technology GlobeNewswire
Mar-31-16 06:20AM  This University of Maryland spinoff just hit the market with its 3-D sound technology at bizjournals.com
Mar-30-16 04:15AM  Oculus Innovative Sciences and Lipogrid of Sweden Announce Strategic Collaboration for Topical Dermatology Drug Delivery at noodls
04:05AM  Oculus Innovative Sciences and Lipogrid of Sweden Announce Strategic Collaboration for Topical Dermatology Drug Delivery GlobeNewswire
Mar-24-16 04:22AM  Oculus Innovative Sciences to Present at the Sidoti Emerging Growth Conference at noodls
04:05AM  Oculus Innovative Sciences to Present at the Sidoti Emerging Growth Conference GlobeNewswire
Mar-23-16 04:07PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements
04:29AM  Oculus Innovative Sciences Announces Multi-Year Licensing Agreement with Manna Pro Products, LLC, for MicrocynAH® Animal Healthcare Products at noodls
04:05AM  Oculus Innovative Sciences Announces Multi-Year Licensing Agreement with Manna Pro Products, LLC, for MicrocynAH® Animal Healthcare Products GlobeNewswire
Mar-18-16 04:07PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements
08:41AM  Oculus Innovative Sciences Announces Pricing of $3.4 Million Underwritten Public Offering GlobeNewswire
Mar-17-16 07:42PM  Oculus Innovative Sciences Announces Proposed Underwritten Public Offering of Common Stock and Warrants GlobeNewswire -5.76%
Mar-09-16 03:05AM  Oculus Innovative Sciences to Present at the Roth Capital Partners 28th Annual Conference GlobeNewswire
Mar-08-16 09:25AM  Dermatologists Praise Multiple Benefits of Oculus Innovative Science's Microcyn Technology Accesswire
Mar-03-16 03:05AM  Oculus Innovative Sciences Receives European Approval to Market Lasercyn Indicated for Use Following Laser Skin Resurfacing GlobeNewswire
Feb-24-16 09:01AM  Stonegate Capital Partners Initiates Coverage on Oculus Innovative Sciences Accesswire
Feb-23-16 09:15AM  Addressing Antibiotic Resistance With Combination Therapies for Acne Accesswire
Feb-18-16 04:05AM  Maxim Group Hosts Key Opinion Leaders Discussing Breakthroughs in Dermatology Relating to Products From Oculus Innovative Sciences GlobeNewswire
Feb-16-16 04:53PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-Q, Quarterly Report +5.32%
Feb-09-16 12:54PM  Oculus Innovative Sciences, Inc. Earnings Analysis: Q3, 2016 By the Numbers
09:25AM  Holding the Course, Oculus Innovative Sciences Delivers Revenue Growth Again Accesswire
Feb-08-16 12:19PM  Edited Transcript of OCLS earnings conference call or presentation 4-Feb-16 9:30pm GMT -17.86%
Feb-05-16 04:05AM  Oculus Innovative Sciences to Present at the Source Capital Group's 2016 Disruptive Growth & Healthcare Conference GlobeNewswire -9.68%
Feb-04-16 04:30PM  Oculus Innovative Sciences Inc Earnings Call scheduled for 4:30 pm ET today
04:06PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme
04:05PM  Oculus Innovative Sciences Reports Third Quarter Financial Results GlobeNewswire
07:07AM  Q3 2016 Oculus Innovative Sciences Inc Earnings Release - After Market Close
Jan-21-16 04:05AM  Oculus Innovative Sciences Announces Fiscal Third Quarter 2016 Financial Results and Conference Call GlobeNewswire +9.52%
Jan-20-16 09:25AM  A Turnaround Story Wall Street Hasn't Caught Onto Yet Accesswire
Jan-14-16 02:45PM  40 under 40: Meet the financial wizards and local economic development leaders (Video) at bizjournals.com
04:05AM  Oculus Innovative Sciences Receives European CE Mark for New MucoClyns for First Responders GlobeNewswire
Jan-13-16 04:45PM  40 under 40: Find out which real estate and legal leaders made the cut (Video) at bizjournals.com +6.74%
Jan-12-16 04:00PM  Announcing 40 Under 40's tech titans in the class of 2016 (Video) at bizjournals.com -7.29%
Jan-08-16 02:43PM  Edited Transcript of OCLS earnings conference call or presentation 5-Nov-15 9:30pm GMT -7.08%
12:13PM  12 Biotechs With Binary Events Coming This Year
06:50AM  8 things you need to know this morning at bizjournals.com
Jan-07-16 09:25AM  Innovation Sparks Advancement of New Treatments for Atopic Dermatitis Accesswire -5.04%
06:32AM  [$$] Fitbit flop shows the perils of new hardware at Financial Times
Jan-05-16 10:00AM  [$$] CES 2016: HTC tweaks virtual reality headset to give 'room scale' at Financial Times
Dec-22-15 09:30AM  The Zacks Analyst Blog Highlights: Streamline Health Solutions, WaferGen Bio-systems, HealthEquity, Oculus Innovative Sciences and LeMaitre Vascular
Dec-21-15 09:45AM  Santa Brings FDA and Health Canada Approvals for New Dermatology Products Accesswire
08:31AM  5 Growth Stocks to Buy on High Obamacare Enrollment
Dec-17-15 04:05AM  Oculus Innovative Sciences Receives FDA Clearance for Microcyn®-Based SebDerm Gel GlobeNewswire
Dec-03-15 11:19AM  Oculus Innovative Sciences, Inc. Earnings Q2, 2016
Dec-01-15 09:33AM  OCLSW: Compelling Leveraged Upside Potential With A Long Time To Expiry Accesswire
Nov-20-15 09:00AM  Samsungs Oculus-powered Gear VR is the Best Money Can Buy at Fortune
Nov-12-15 09:15AM  Oculus Innovative Sciences Beats Analyst Expectations, Even More than at First Blush Accesswire
Nov-10-15 04:17PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-Q, Quarterly Report
Nov-05-15 04:30PM  Oculus Innovative Sciences Inc Earnings Call scheduled for 4:30 pm ET today
04:07PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme
04:05PM  Oculus Innovative Sciences Reports Financial Results for the Second Quarter of Fiscal Year 2016 GlobeNewswire
Nov-03-15 12:08PM  Oculus Innovative Sciences, Inc. Value Analysis (NASDAQ:OCLS) : November 3, 2015
09:15AM  Earnings on Tap: Glu Mobile and Oculus Innovative Sciences Accesswire
Oct-27-15 04:48PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,
Oct-22-15 05:21PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders
06:05AM  Oculus Innovative Sciences Announces Fiscal Second Quarter 2016 Financial Results and Conference Call GlobeNewswire
Oct-20-15 09:10AM  Oculus Has Made Significant Gains In The Dermatology Industry After Just One Year Accesswire
Oct-16-15 05:00PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Oct-15-15 04:07PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Oct-08-15 09:27AM  Prescription Scar Gel Leads Oculus' Charge in Dermatology Accesswire
Oct-01-15 10:39AM  Oculus Innovative Sciences, Inc. Earnings Q1, 2016
Oculus Innovative Sciences, Inc. designs, produces, and markets prescription and over-the-counter products based on its Microcyn platform technology for the dermatology, surgical, advanced tissue, skincare, and animal healthcare markets in the United States, Latin America, Europe, and rest of the world. The Microcyn platform technology is based on electrically charged oxychlorine small molecules, which are designed to target a range of pathogens that cause disease, including viruses, fungi, spores, and bacteria, such as antibiotic-resistant strains. The company's Microcyn has received fourteen 510(k) clearances for use as a medical device in tissue care management consisting of acute and chronic wounds, and in dermatology applications. It also provides consulting and laboratory services to medical companies that design and manufacture biomedical devices and drugs. Oculus Innovative Sciences, Inc. sells its products directly to end users and distributors, and through contract sales force and business partners to hospitals, physicians, nurses, and other healthcare practitioners, as well as to dermatologists for the treatment of various skin afflictions. The company was formerly known as Micromed Laboratories, Inc. and changed its name to Oculus Innovative Sciences, Inc. in August 2001. Oculus Innovative Sciences, Inc. was incorporated in 1999 and is headquartered in Petaluma, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schutz James JChief Executive OfficerAug 15Buy3.661,3284,8666,505Aug 16 04:05 PM
Schutz James JChief Executive OfficerFeb 25Buy1.005,0005,00025,885Feb 29 06:00 AM